Older corneas "just as good" for transplant

Article

Corneas from donors up to the age of 75 are suitable for transplantation, according to a study published in the April 2008 issue of Ophthalmology.

Corneas from donors up to the age of 75 are suitable for transplantation, according to a study published in the April 2008 issue of Ophthalmology.

Edward Holland, MD of the University of Rochester Medical Center, US and colleagues on the Cornea Donor Study conducted the multicentre prospective, double-masked, controlled five-year trial of 1090 subjects to establish a comparison between graft survival in tissue from donors under the age of 65 with tissue taken from older donors.

Probability of graft failure, defined as three months’ consecutive impact on vision due to corneal opacity or regraft requirement, was 14% across both donor age groups (<66 years and ≥66 years). There was no statistically significant correlation between donor age and graft failure or survival, nor was there a statistically significant difference between age groups over the causes of graft failure.

Thus the researchers concluded that donor age is not a significant variable in graft failure. Dr Holland estimates that this will increase the pool of available donor corneas by 25–30%.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.